Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-285,547
Closed -$17.4M 124
2018
Q2
$17.4M Sell
285,547
-179,986
-39% -$10.9M 0.41% 80
2018
Q1
$27.9M Sell
465,533
-128,629
-22% -$7.75M 0.61% 66
2017
Q4
$33.9M Sell
594,162
-369,098
-38% -$20.5M 0.78% 52
2017
Q3
$51.4M Sell
963,260
-115,740
-11% -$5.81M 1.3% 26
2017
Q2
$52.5M Sell
1,079,000
-83,100
-7% -$3.76M 1.28% 32
2017
Q1
$51.6M Buy
1,162,100
+641,100
+123% +$27.7M 1.2% 27
2016
Q4
$20M Buy
+521,000
New +$20.7M 0.45% 69

Other funds holding ABT

Samlyn Capital's ABT Position: Q3 2018 in Review

Samlyn Capital sold out of Abbott (ABT) in Q3 2018, closing a stake of 285,547 shares — an estimated $17.4M sold.

Samlyn Capital first reported a position in ABT in Q4 2016 and held it in 7 quarters. The position peaked at $52.5M in Q2 2017. 1,868 funds tracked by Wall St. Rank hold ABT as of Q3 2018.

  • Samlyn Capital reported no remaining Abbott position as of Q3 2018 after selling out during the quarter.
  • Samlyn Capital sold 285,547 Abbott shares in Q3 2018, an estimated $17.4M.
  • Samlyn Capital first reported a position in Abbott in Q4 2016 and held it in 7 quarters.
  • Samlyn Capital's Abbott position peaked at $52.5M in Q2 2017.
  • 1,868 funds tracked by Wall St. Rank held Abbott as of Q3 2018.

Based on Samlyn Capital's 13F filing for Q3 2018, filed 14 Nov 2018.